4//SEC Filing
Chen Jing 4
Accession 0001144204-19-029892
CIK 0001563665other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:30 PM ET
Size
10.4 KB
Accession
0001144204-19-029892
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
Chen Jing
Director
Transactions
- Award
Stock Option (right to buy)
2019-06-03+8,411→ 18,775 totalExercise: $2.90Exp: 2029-06-03→ Common Stock, par value $0.01 per share (8,411 underlying) - Award
Stock Option (right to buy)
2019-06-03+10,364→ 10,364 totalExercise: $2.90Exp: 2029-06-03→ Common Stock, par value $0.01 per share (10,364 underlying) - Award
Stock Option (right to buy)
2019-06-03+7,554→ 26,329 totalExercise: $2.90From: 2019-06-03Exp: 2029-06-03→ Common Stock, par value $0.01 per share (7,554 underlying)
Footnotes (3)
- [F1]This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 3, 2019, December 3, 2019, March 3, 2020, and June 3, 2020.
- [F2]This Stock Option was granted in lieu of 2019 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2019, September 30, 2019, and December 31, 2019.
- [F3]This Stock Option was granted in lieu of 2018 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer.
Documents
Issuer
Biostage, Inc.
CIK 0001563665
Entity typeother
Related Parties
1- filerCIK 0001727177
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:30 PM ET
- Size
- 10.4 KB